Chen, Y., Xu, S., & Duan, R. (2015). Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells. Lipids Health Dis.
Chicago ZitierstilChen, Ying, Shu-Chang Xu, und Rui-Dong Duan. "Mevalonate Inhibits Acid Sphingomyelinase Activity, Increases Sphingomyelin Levels and Inhibits Cell Proliferation of HepG2 and Caco-2 Cells." Lipids Health Dis 2015.
MLA ZitierstilChen, Ying, Shu-Chang Xu, und Rui-Dong Duan. "Mevalonate Inhibits Acid Sphingomyelinase Activity, Increases Sphingomyelin Levels and Inhibits Cell Proliferation of HepG2 and Caco-2 Cells." Lipids Health Dis 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.